Sfoglia per Autore  DE SANCTIS, Rita

Opzioni
Mostrati risultati da 1 a 20 di 111
Titolo Data di pubblicazione Autore(i) File
[The clinical significance of lymph node micrometastases and of concept of sentinel lymph node] 1-gen-2006 Forte, A; Leonetti, G; Bosco, M; Manfredelli, S; De Sanctis, R; Urbano, V; Bezzi, M
First-line chemotherapy in over-70 patients with colon cancer. 1-gen-2007 Raimondi, C; Rosati, Ms; Bianco, V; Graziano, V; Stumbo, L; Recine, F; Restuccia, M; De Sanctis, R; Giovannoni, S; Di Seri, M
WALT TRIAL (PHASE III): WEEKLY NON PEGYLATED LIPOSOMAL ANTHRACYCLINE AND TAXANE COMBINATION IN FIRSTLINE BREAST CANCER CHEMOTHERAPY 1-gen-2008 Rosati, Ms; Raimondi, C; Quadrini, S; DE SANCTIS, R; Baciarello, G; M., Girolami; Basile, Ml; Poleggi, Mp; DI SERI, M
Docetaxel in combination with gemcitabine as second line treatment in patients with platinum resistant advanced NSCLC 1-gen-2008 Gori, B; Longo, F; Zivi, A; De Sanctis, R; Del Signore, E; Proietti, E; Sperduti, I; De Filippis, L; Stumbo, L; Quadrini, S; Di Seri, M
Carcinoma gastrico metastatico e Docetaxel, Cisplatino, Fluorouracile (DCF) settimanale: tolleranza e risposta 1-gen-2008 Recine, F; De Sanctis, R; Sollami, R; Falbo, Pt; Fulvi, A; Tedeschi, M; Quadrini, S; Longo, F; Di Seri, M
Bevacizumab in combination with FOLFIRI as first-line treatment for metastatic colorectal cancer: outcomes from a single center experience 1-gen-2008 De Sanctis, R; Cerbone, L; Sacco, Pc; Sollami, R; Fulvi, A; Petrelli, E; Girolami, M; Bianco, V; Longo, F; Di Seri, M
Safety and efficacy of bevacizumab with first-line FOLFIRI for metastatic colorectal cancer: single center experience 1-gen-2008 Longo, F; De Sanctis, R; Quadrini, S; Stumbo, L; Del Signore, E; Gori, B; De Filippis, L; Di Seri, M
wALT trial (Phase I-II): weekly non-pegylated liposomal anthracycline and taxane combination in first line breast cancer chemotherapy 1-gen-2008 Rosati, Ms; Raimondi, C; Quadrini, S; De Sanctis, R; Stumbo, L; Gori, B; Del Signore, E; Poleggi, Mp; Di Seri, M.
[Integrated treatment of breast cancer: review of our experience] 1-gen-2008 Forte, A; De Sanctis, R; Manfredelli, S; Leonetti, G; Covotta, A; Urbano, V; Bezzi, M
Dietary chemoprevention of colorectal cancer 1-gen-2008 A., Forte; DE SANCTIS, R; Leonetti, G; Manfredelli, S; Urbano, V; Bezzi, M
Zoledronic acid (ZA) and treatment of bone metastasis in patients with advanced lung cancer (NSCLC and SCLC). 1-gen-2008 Del Signore, E; Zivi, A; Cerbone, L; Recine, F; Raimondi, C; De Sanctis, R; Quadrini, S; Grassi, P; Basile, Ml; Minisola, S; Fassino, V; Longo, L; Di Seri, M
Colorectal cancer liver metastases treated with target therapies: monitoring response with contrast-enhanced ultrasonography (CE-US). 1-gen-2009 Quadrini, S; De Sanctis, R; Stumbo, L; Gori, B; Del Signore, E; De Filippis, L; Ricci, P; Cantisani, V; Di Seri, M; Longo, F
The role of docetaxel in the multimodal treatment of non-small cell lung cancer 1-gen-2009 De Sanctis, R; D’Antoni, I; Del Signore, E; Gori, B; Longo, F
Colorectal cancer liver metastases treated with target therapies: monitoring response with constrat-enhanced ultrasonography (CE-US). 1-gen-2009 De Sanctis, R; Quadrini, S; Stumbo, L; Gori, B; Del Signore, E; Adua, D; Recine, F; De Filippis, L; Longo, F; Di Seri, M
Oral vinorelbine in elderly or unfit patients with metastatic NSCLC 1-gen-2009 Stumbo, L; Gori, B; Del Signore, E; De Sanctis, R; De Filippis, L; Fratellizzi, V; Lapadula, V; D’Antoni, I; Adua, D; Di Seri, M; Longo, F
Early response evaluation of antiangiogenic therapy: use of contrast-enhanced ultrasonography (CE-US) in hepatocellular carcinoma 1-gen-2009 De Sanctis, R; Quadrini, S; Tedeschi, M; Stumbo, L; Gori, B; Del Signore, E; Ricci, P; Cantisani, V; Di Seri, M; Longo, F
Palonosetron plus three-day aprepitant and dexamethasone schedule to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 1-gen-2009 De Sanctis, R; Longo, F; Mansueto, G; Lapadula, V; Grande, R; Quadrini, S; Gori, B; Altavilla, A; D’Antoni, I; Del Signore, E; Stumbo, L; Cimadon, B; Cortesi, E; Gamucci, T; Di Seri, M
Safety, Tollerability and Early Response Evaluation of Sorafenib In Hepatocellular Carcinoma In Elderly: Use of Contrast-enhanced Ultrasonography (ce-us) 1-gen-2009 V., Bianco; I., Speranza; S., Quadrini; DE SANCTIS, Rita; Brozzetti, Stefania; G., De Santis; V., Cantisani; P., Ricci; F., Longo; DI SERI, Marisa; Frati, Luigi
Safety, tolerability and early response evaluation of sarafenib in hepatocellular carcinoma in erderly: use of contrast-enhanced ultrasonography (CE-US). 1-gen-2009 Bianco, V; Speranza, I; Quadrini, S; De Sanctis, R; Bronzetti, S; De Santis, G; Cantisani, V; Ricci, ; Longo, F; Di Seri, M P; Frati, L
Efficacy and tolerability of a single-day three drugs combination of aprepitant, palonosetron and dexamethasone in patients receiving moderately emetogenic chemotherapy 1-gen-2009 Quadrini, S; Longo, F; Lapadula, V; Stumbo, L; De Sanctis, R; D’Antoni, I; Del Signore, E; Gori, B; Viggiani, E; Vairanom, ; Di Seri, M
Mostrati risultati da 1 a 20 di 111
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile